ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
68.172,83
0,66%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. enGene Holdings Inc (ENGN)

  7. enGene Holdings Inc (ENGN) News

ENGN

enGene (ENGN)

enGene Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ENGN
DatumZeitQuelleÜberschriftSymbolFirma
29/05/202413h30Business WireenGene to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ENGNenGene Holdings Inc
15/05/202422h05Business WireenGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
02/05/202422h05PR Newswire (US)enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual MeetingNASDAQ:ENGNenGene Holdings Inc
02/05/202422h05PR Newswire (Canada)enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual MeetingNASDAQ:ENGNenGene Holdings Inc
09/04/202414h56PR Newswire (US)/C O R R E C T I O N -- enGene Inc./NASDAQ:ENGNenGene Holdings Inc
09/04/202414h00PR Newswire (US)engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical DevelopmentNASDAQ:ENGNenGene Holdings Inc
09/04/202414h00PR Newswire (Canada)engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical DevelopmentNASDAQ:ENGNenGene Holdings Inc
11/03/202422h16PR Newswire (Canada)enGene Reports First Quarter 2024 Financial Results and Recent Corporate ProgressNASDAQ:ENGNenGene Holdings Inc
11/03/202422h16PR Newswire (US)enGene Reports First Quarter 2024 Financial Results and Recent Corporate ProgressNASDAQ:ENGNenGene Holdings Inc
05/03/202413h00PR Newswire (US)enGene To Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ENGNenGene Holdings Inc
05/03/202413h00PR Newswire (Canada)enGene To Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ENGNenGene Holdings Inc
14/02/202412h50PR Newswire (Canada)enGene Announces Oversubscribed $200 Million Private Placement FinancingNASDAQ:ENGNenGene Holdings Inc
14/02/202412h50PR Newswire (US)enGene Announces Oversubscribed $200 Million Private Placement FinancingNASDAQ:ENGNenGene Holdings Inc
14/02/202412h45PR Newswire (Canada)enGene Announces Leadership Succession PlanNASDAQ:ENGNenGene Holdings Inc
14/02/202412h45PR Newswire (US)enGene Announces Leadership Succession PlanNASDAQ:ENGNenGene Holdings Inc
30/01/202413h00PR Newswire (Canada)enGene Appoints Lee Giguere as Chief Legal Officer and Corporate SecretaryNASDAQ:ENGNenGene Holdings Inc
30/01/202413h00PR Newswire (US)enGene Appoints Lee Giguere as Chief Legal Officer and Corporate SecretaryNASDAQ:ENGNenGene Holdings Inc
29/01/202413h00PR Newswire (Canada)enGene Reports Full Year 2023 Financial Results and Recent Operational ProgressNASDAQ:ENGNenGene Holdings Inc
29/01/202413h00PR Newswire (US)enGene Reports Full Year 2023 Financial Results and Recent Operational ProgressNASDAQ:ENGNenGene Holdings Inc
22/12/202323h00PR Newswire (Canada)enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalNASDAQ:ENGNenGene Holdings Inc
22/12/202323h00PR Newswire (US)enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalNASDAQ:ENGNenGene Holdings Inc
19/12/202313h00PR Newswire (US)enGene Appoints Lota S. Zoth, CPA, as Member of the Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
19/12/202313h00PR Newswire (Canada)enGene Appoints Lota S. Zoth, CPA, as Member of the Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
29/11/202313h00PR Newswire (Canada)enGene Appoints Ryan Daws as Chief Financial OfficerNASDAQ:ENGNenGene Holdings Inc
29/11/202313h00PR Newswire (US)enGene Appoints Ryan Daws as Chief Financial OfficerNASDAQ:ENGNenGene Holdings Inc
16/02/201212h30Dow Jones NewsBlackRock Set To Slice Corporate Bond ETFs By SectorNASDAQ:ENGNiShares Industrials Sector Bond Fund
 Showing the most relevant articles for your search:NASDAQ:ENGN

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
TG
MBG
MercedesBenz
NASDAQ
AMZN
Amazon.com
FX
EURGBP
Euro vs Sterling
NYSE
MRK
Merck
DBI
MDAX
MDAX
NASDAQ
MSFT
Microsoft
DBI
SDXP
SDAX
NASDAQ
TSLA
Tesla
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
DTE
Deutsche Telekom
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten